Nanuet, NY, United States of America

N Ragunathan


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor N Ragunathan

Introduction

N Ragunathan, an accomplished inventor based in Nanuet, NY, has made significant strides in the pharmaceutical industry. With a focus on enhancing drug delivery systems, she holds a patent that showcases her innovative approach to pharmaceutical compositions.

Latest Patents

Ragunathan's most notable patent is titled "Flocculated suspension of megestrol acetate." This patent describes a novel oral pharmaceutical composition that presents as a stable flocculated suspension in water. It comprises megestrol acetate combined with compounds such as polyethylene glycol, propylene glycol, glycerol, and sorbitol, along with a surfactant, ensuring that polysorbate and polyethylene glycol are not simultaneously present. This innovation holds potential benefits for improving the bioavailability and effectiveness of medications.

Career Highlights

Throughout her career, N Ragunathan has been an integral part of Pharmaceutical Resources Inc., where she has contributed to numerous projects aimed at developing advanced pharmaceutical formulations. Her dedication to research and innovation in the field has earned her recognition among her peers.

Collaborations

Working alongside talented colleagues such as James C Chao and Robert A Femia, Ragunathan has forged collaborations that leverage their combined expertise in pharmaceutical sciences. These partnerships have led to the development of cutting-edge solutions that address various medical needs.

Conclusion

In conclusion, N Ragunathan stands out as a pioneering inventor in the pharmaceutical industry. Her patent for a flocculated suspension of megestrol acetate exemplifies her commitment to enhancing drug formulations. With ongoing collaborations and a strong career trajectory, she continues to pave the way for future innovations in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…